Birmingham Psychiatry Pharmaceutical Studies, Inc — Birmingham, Alabama

Birmingham Psychiatry Pharmaceutical Studies, Inc is a clinical research site located in Birmingham, Alabama, United States 35226.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Birmingham Psychiatry Pharmaceutical Studies, Inc has participated in 3 clinical trials.

Therapeutic areas: Bipolar I Depression, Major Depressive Disorder, Depression.

Sponsors: Cephalon, Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Psychiatry Pharmaceutical Studies, Inc?

Birmingham Psychiatry Pharmaceutical Studies, Inc has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Psychiatry Pharmaceutical Studies, Inc conducted?

Birmingham Psychiatry Pharmaceutical Studies, Inc has 3 clinical trials on record. Their work covers Bipolar I Depression, Major Depressive Disorder, Depression.

Is Birmingham Psychiatry Pharmaceutical Studies, Inc accredited by Crixeo Health?

Birmingham Psychiatry Pharmaceutical Studies, Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Birmingham Psychiatry Pharmaceutical Studies, Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.